<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki-spirit.win/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Amycarter06</id>
	<title>Wiki Spirit - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://wiki-spirit.win/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Amycarter06"/>
	<link rel="alternate" type="text/html" href="https://wiki-spirit.win/index.php/Special:Contributions/Amycarter06"/>
	<updated>2026-07-21T15:36:19Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.42.3</generator>
	<entry>
		<id>https://wiki-spirit.win/index.php?title=How_Do_You_Add_Proprietary_Business_Context_to_Enterprise_AI%3F&amp;diff=2378496</id>
		<title>How Do You Add Proprietary Business Context to Enterprise AI?</title>
		<link rel="alternate" type="text/html" href="https://wiki-spirit.win/index.php?title=How_Do_You_Add_Proprietary_Business_Context_to_Enterprise_AI%3F&amp;diff=2378496"/>
		<updated>2026-07-21T03:02:46Z</updated>

		<summary type="html">&lt;p&gt;Amycarter06: Created page with &amp;quot;&amp;lt;html&amp;gt;```html&amp;lt;p&amp;gt; As generative AI tools like &amp;lt;strong&amp;gt; ChatGPT&amp;lt;/strong&amp;gt; captivate consumers with impressive and entertaining outputs, enterprises face a very different challenge: leveraging AI for high-stakes decisions while managing risk and ensuring trust. This is especially critical in regulated, complex domains such as life sciences, where business context and domain knowledge are not just nice-to-have — they are essential to safe, effective AI adoption.&amp;lt;/p&amp;gt; In this...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;html&amp;gt;```html&amp;lt;p&amp;gt; As generative AI tools like &amp;lt;strong&amp;gt; ChatGPT&amp;lt;/strong&amp;gt; captivate consumers with impressive and entertaining outputs, enterprises face a very different challenge: leveraging AI for high-stakes decisions while managing risk and ensuring trust. This is especially critical in regulated, complex domains such as life sciences, where business context and domain knowledge are not just nice-to-have — they are essential to safe, effective AI adoption.&amp;lt;/p&amp;gt; In this blog post, we&#039;ll explore why simply deploying consumer AI tools isn&#039;t sufficient for enterprise use, the risks posed by AI hallucinations, and how proprietary business context can be integrated into enterprise AI models. Drawing on &amp;lt;a href=&amp;quot;https://trinitylifesciences.com/blog/enterprise-ai-disappointment-life-sciences/&amp;quot;&amp;gt;&amp;lt;strong&amp;gt;Click for info&amp;lt;/strong&amp;gt;&amp;lt;/a&amp;gt; insights from Trinity Life Sciences, McKinsey&#039;s QuantumBlack – The State of AI report, and Forbes analysis, we&#039;ll unpack how companies are building AI solutions grounded in domain knowledge, powered by AI-ready data and enhanced by a context layer. &amp;lt;h2&amp;gt; From Consumer AI Delight to Enterprise AI Trust&amp;lt;/h2&amp;gt; &amp;lt;p&amp;gt; Consumer AI tools like ChatGPT excel at generating fluent, creative, and engaging responses for end users. This &amp;quot;delight factor&amp;quot; drives massive adoption across industries and consumer segments. However, as highlighted repeatedly in McKinsey’s QuantumBlack The State of AI report, the requirements for enterprise AI are far more stringent:&amp;lt;/p&amp;gt; &amp;lt;ul&amp;gt;  &amp;lt;li&amp;gt; &amp;lt;strong&amp;gt; Accuracy:&amp;lt;/strong&amp;gt; Decisions often have financial, regulatory, or safety consequences.&amp;lt;/li&amp;gt; &amp;lt;li&amp;gt; &amp;lt;strong&amp;gt; Explainability:&amp;lt;/strong&amp;gt; Stakeholders demand transparency into AI outputs.&amp;lt;/li&amp;gt; &amp;lt;li&amp;gt; &amp;lt;strong&amp;gt; Trust:&amp;lt;/strong&amp;gt; Enterprises need reliable, reproducible insights, not just plausible-sounding text.&amp;lt;/li&amp;gt; &amp;lt;li&amp;gt; &amp;lt;strong&amp;gt; Compliance:&amp;lt;/strong&amp;gt; Regulatory frameworks require traceability and validation.&amp;lt;/li&amp;gt; &amp;lt;/ul&amp;gt; &amp;lt;p&amp;gt; For life sciences companies, as Trinity Life Sciences emphasizes, these factors multiply exponentially — every AI model must incorporate deep domain expertise and proprietary data to avoid costly errors.&amp;lt;/p&amp;gt; &amp;lt;h3&amp;gt; Hallucinations and Business Risk in Life Sciences&amp;lt;/h3&amp;gt; &amp;lt;p&amp;gt; One of the most serious challenges when deploying consumer-grade generative AI in regulated industries is &amp;quot;hallucinations&amp;quot; — AI-generated information that is plausible but factually incorrect or fabricated. While harmless in a casual conversation, hallucinations can trigger major risks for life sciences enterprises:&amp;lt;/p&amp;gt; &amp;lt;ul&amp;gt;  &amp;lt;li&amp;gt; Misinforming clinical trial strategies or drug safety assessments&amp;lt;/li&amp;gt; &amp;lt;li&amp;gt; Misinterpreting market access conditions leading to flawed pricing models&amp;lt;/li&amp;gt; &amp;lt;li&amp;gt; Violating compliance requirements through inaccurate reporting&amp;lt;/li&amp;gt; &amp;lt;/ul&amp;gt; &amp;lt;p&amp;gt; For instance, a hallucinated drug interaction or patient outcome could result in flawed treatment recommendations or delayed regulatory approvals, impacting patient safety and company reputation. This risk emphasizes why context and domain knowledge are paramount.&amp;lt;/p&amp;gt; &amp;lt;h2&amp;gt; Bridging the Proprietary Context and Domain Knowledge Gaps&amp;lt;/h2&amp;gt; &amp;lt;p&amp;gt; AI models like ChatGPT are typically trained on vast public data sets but lack visibility into an organization&#039;s proprietary knowledge base — clinical trial data, payer contracts, in-house R&amp;amp;D, or real-world evidence repositories. Without this proprietary context, models may generate generic or inaccurate insights unsuitable for life sciences business decisions.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt; &amp;lt;img  src=&amp;quot;https://images.pexels.com/photos/6491956/pexels-photo-6491956.jpeg?auto=compress&amp;amp;cs=tinysrgb&amp;amp;h=650&amp;amp;w=940&amp;quot; style=&amp;quot;max-width:500px;height:auto;&amp;quot; &amp;gt;&amp;lt;/img&amp;gt;&amp;lt;/p&amp;gt; &amp;lt;p&amp;gt; Trinity AI, Trinity Life Sciences’ proprietary AI platform, addresses this gap by embedding proprietary business context directly into generative AI workflows. Here’s how the approach differs from using consumer AI “as is”:&amp;lt;/p&amp;gt; &amp;lt;ol&amp;gt;  &amp;lt;li&amp;gt; &amp;lt;strong&amp;gt; Context Layer Datasets:&amp;lt;/strong&amp;gt; Curated datasets that combine proprietary data (e.g., internal market access databases) with external validated sources.&amp;lt;/li&amp;gt; &amp;lt;li&amp;gt; &amp;lt;strong&amp;gt; Domain-Specific Fine-Tuning:&amp;lt;/strong&amp;gt; Models are fine-tuned on industry-specific documents, terminology, and regulatory frameworks to improve relevance and accuracy.&amp;lt;/li&amp;gt; &amp;lt;li&amp;gt; &amp;lt;strong&amp;gt; Human-in-the-Loop Processes:&amp;lt;/strong&amp;gt; Continuous expert review and feedback loops ensure outputs are validated before consumption by business users.&amp;lt;/li&amp;gt; &amp;lt;/ol&amp;gt; &amp;lt;p&amp;gt; These elements create an &amp;quot;enterprise-grade&amp;quot; AI environment where outputs are not only fluent but factually consistent with corporate knowledge and compliant with industry standards.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt; &amp;lt;img  src=&amp;quot;https://images.pexels.com/photos/9574518/pexels-photo-9574518.jpeg?auto=compress&amp;amp;cs=tinysrgb&amp;amp;h=650&amp;amp;w=940&amp;quot; style=&amp;quot;max-width:500px;height:auto;&amp;quot; &amp;gt;&amp;lt;/img&amp;gt;&amp;lt;/p&amp;gt; &amp;lt;h3&amp;gt; Enterprise AI Domain Knowledge: More Than Data, It’s Context&amp;lt;/h3&amp;gt; &amp;lt;p&amp;gt; Forbes recently highlighted that simply feeding data into AI is not enough — enterprises must develop an AI &amp;quot;context layer&amp;quot; that turns raw data into actionable insights tailored to business needs. This context layer includes:&amp;lt;/p&amp;gt; &amp;lt;ul&amp;gt;  &amp;lt;li&amp;gt; Data relationships that mirror real-world business scenarios&amp;lt;/li&amp;gt; &amp;lt;li&amp;gt; Metadata capturing provenance, quality, and relevance for decision transparency&amp;lt;/li&amp;gt; &amp;lt;li&amp;gt; Taxonomies and ontologies reflecting industry-specific terminologies and processes&amp;lt;/li&amp;gt; &amp;lt;/ul&amp;gt; &amp;lt;p&amp;gt; In practice, this means a pharma company might build a context layer merging clinical trial outcomes, regulatory pathways, and payer reimbursement data, enabling AI to generate precise recommendations for pipeline prioritization or pricing strategies.&amp;lt;/p&amp;gt; &amp;lt;h2&amp;gt; Building AI-Ready Data Plus a Context Layer: A Practical Roadmap&amp;lt;/h2&amp;gt; &amp;lt;p&amp;gt; How can life sciences enterprises build this essential context layer combined with AI-ready data to power trustworthy AI initiatives?&amp;lt;/p&amp;gt; &amp;lt;h3&amp;gt; Step 1: Audit and Curate Proprietary Data Sources&amp;lt;/h3&amp;gt; &amp;lt;p&amp;gt; Identify all relevant internal datasets, including:&amp;lt;/p&amp;gt; &amp;lt;ul&amp;gt;  &amp;lt;li&amp;gt; Clinical trial and patient outcomes data&amp;lt;/li&amp;gt; &amp;lt;li&amp;gt; Medical affairs insights and expert reports&amp;lt;/li&amp;gt; &amp;lt;li&amp;gt; Market access and pricing contract databases&amp;lt;/li&amp;gt; &amp;lt;li&amp;gt; Regulatory submissions and correspondence&amp;lt;/li&amp;gt; &amp;lt;li&amp;gt; Patient advocacy and real-world evidence (RWE) repositories&amp;lt;/li&amp;gt; &amp;lt;/ul&amp;gt; &amp;lt;p&amp;gt; Assess data quality, completeness, and compliance readiness. Clean and harmonize formats to create interoperable sources.&amp;lt;/p&amp;gt; &amp;lt;h3&amp;gt; Step 2: Develop Ontologies and Business Taxonomies&amp;lt;/h3&amp;gt; &amp;lt;p&amp;gt; Work with domain experts to build standardized vocabularies that accurately map relationships between concepts relevant to the business. For example, link indications with relevant payer types, geographic markets, and treatment guidelines.&amp;lt;/p&amp;gt; &amp;lt;h3&amp;gt; Step 3: Integrate External Validated Data&amp;lt;/h3&amp;gt; &amp;lt;p&amp;gt; Combine proprietary data with validated third-party datasets (e.g., epidemiological reports, pricing benchmarks) to enhance the context while ensuring auditability and provenance.&amp;lt;/p&amp;gt; &amp;lt;h3&amp;gt; Step 4: Leverage AI Platforms Customized for Enterprise Use&amp;lt;/h3&amp;gt; &amp;lt;p&amp;gt; Deploy AI models fine-tuned for your industry and business context, such as Trinity AI, which combines proprietary context layers with generative AI capabilities to power life sciences workflows including forecasting, market access, and brand strategy.&amp;lt;/p&amp;gt; &amp;lt;h3&amp;gt; Step 5: Establish Rigorous Human-in-the-Loop Review&amp;lt;/h3&amp;gt; &amp;lt;p&amp;gt; Embed domain experts in the model output validation process to continuously monitor, correct, and improve AI recommendations. This builds user confidence and reduces risk.&amp;lt;/p&amp;gt; &amp;lt;h2&amp;gt; Conclusion: Driving Enterprise AI Success with Proprietary Context&amp;lt;/h2&amp;gt; &amp;lt;p&amp;gt; Enterprises can no longer rely on the “black box” consumer AI paradigm when making critical business decisions, especially in life sciences. As emphasized by McKinsey&#039;s QuantumBlack – The State of AI and industry leaders like Trinity Life Sciences, achieving enterprise AI trust requires embedding proprietary business context and domain knowledge through carefully constructed context layers and AI-ready data.&amp;lt;/p&amp;gt; &amp;lt;p&amp;gt; By customizing AI models, integrating curated proprietary datasets, and implementing strong validation processes, companies can unlock AI’s transformative potential without sacrificing trust or compliance. Tools like Trinity AI illustrate how this balanced approach bridges the gap between generative AI&#039;s consumer appeal and the rigorous demands of enterprise life sciences workflows.&amp;lt;/p&amp;gt; &amp;lt;p&amp;gt; With AI maturing rapidly, companies that invest in building this proprietary context foundation will gain a critical competitive advantage — delivering better insights, reducing business risk, and accelerating innovation in an increasingly complex market.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt; &amp;lt;iframe  src=&amp;quot;https://www.youtube.com/embed/Zu4tPN4GnqE&amp;quot; width=&amp;quot;560&amp;quot; height=&amp;quot;315&amp;quot; style=&amp;quot;border: none;&amp;quot; allowfullscreen=&amp;quot;&amp;quot; &amp;gt;&amp;lt;/iframe&amp;gt;&amp;lt;/p&amp;gt; ```&amp;lt;/html&amp;gt;&lt;/div&gt;</summary>
		<author><name>Amycarter06</name></author>
	</entry>
</feed>